Document is current
Any future updates will be listed below
-
Authors
Murphy, Michael P. https://orcid.org/0000-0003-1115-9618
Chouchani, Edward T.
- License Information
-
More Information
Article History
Received: 25 September 2021
Accepted: 25 February 2022
First Online: 28 April 2022
Competing interests
: E.T.C. is a founder, board member and equity holder in Matchpoint Therapeutics. M.P.M. holds shares in Antipodean Pharmaceuticals Inc. E.T.C. and M.P.M. hold patents in the field of therapeutic modulation of succinate metabolism.
